Gilead Sciences (GILD) Potential M&A In Focus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. SAP
7. CSX
8. LRCX
9. MRK
10. LVS

Go back to Gilead Sciences (GILD) Potential M&A In Focus

Gilead Sciences Announces Fourth Quarter and Full Year 2015 Financial Results

February 2, 2016 4:00 PM EST

- Fourth Quarter Product Sales of $8.4 billion, Up 16 percent Year over Year -

- Full Year 2015 Product Sales of $32.2 billion, Up 31 percent Year over Year -

- Full Year 2015 Non-GAAP EPS of $12.61, Up 56 percent Year over Year -

FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the fourth quarter and full year 2015. Total revenues for the fourth quarter of 2015 were $8.5 billion compared to $7.3 billion for the fourth quarter of... More